SCHEMBL4906172

SCHEMBL4906172

CC(C)(C)OC(=O)N[C@@H](CCCN)C(=O)N1CCC[C@H]1C#N

nearest known ligand 0.55

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 6/20 0.55
DPP7 Q9UHL4 5/20 0.55
DPP8 Q6V1X1 3/20 0.55
DPP9 Q86TI2 2/20 0.55
ITGB3 P05106 8/20 0.52
ITGA2B P08514 8/20 0.52
PREP P48147 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905274 0.97 DPP4 (0.59) DPP4DPP7DPP8DPP9ITGB3
SCHEMBL8250574 0.89 DPP4 (0.54) DPP4DPP7DPP8DPP9PREP
SCHEMBL5366307 0.88 DPP4 (0.50) DPP4DPP7DPP8DPP9PREP
SCHEMBL5366301 0.86 PREP (0.48) DPP4DPP8DPP9ITGB3ITGA2B
SCHEMBL6111437 0.86 PREP (0.48) DPP4DPP8DPP9ITGB3ITGA2B
SCHEMBL5916433 0.86 PREP (0.48) DPP4DPP8DPP9ITGB3ITGA2B
SCHEMBL13034909 0.86 ITGB3 (0.47) DPP4DPP7DPP8DPP9ITGB3
SCHEMBL13035141 0.84 DPP4 (0.46) DPP4DPP8DPP9PREP
SCHEMBL3601946 0.84 CTSL (0.51) DPP4DPP8DPP9PREP
SCHEMBL13444797 0.84 DPP4 (0.50) DPP4DPP8DPP9ITGB3ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255126-A1 Inhibitors of post-proline cleaving proteases FERRING B.V. 2008-10-16 US disclosed
US-7335677-B2 Inhibitors of dipeptidyl peptidase IV FERRING B.V. (NL) 2008-02-26 US disclosed
US-7189728-B2 Inhibitors of dipeptidyl peptidase IV FERRING, BV (NL) 2007-03-13 US disclosed
US-7144886-B2 Dipeptidyl peptidase IV (DP-IV) inhibitors as anti-diabetic agents FERRING B.V. (NL) 2006-12-05 US disclosed
US-7125863-B2 Inhibitors of dipeptidyl peptidase IV FERRING BV (NL) 2006-10-24 US disclosed
EP-1693365-A1 Inhibitors of dipeptidyl peptidase IV FERRING B.V. (NL) 2006-08-23 EP disclosed
US-20050043299-A1 Inhibitors of dipeptidyl peptidase iv FERRING B. V. 2005-02-24 US disclosed
US-20050004205-A1 Novel dipeptidyl peptidase iv (dp-iv) inhibitors as anti-diabetic agents FERRING B.V. (NL) 2005-01-06 US disclosed
EP-1280797-B1 INHIBITORS OF DIPEPTIDYL PEPTIDASE IV FERRING BV (NL) 2004-10-13 EP disclosed
US-20040082497-A1 Inhibitors of dipeptidyl peptidase IV FERRING BV (NL) 2004-04-29 US disclosed
US-20030216450-A1 Inhibitors of dipeptidyl peptidase IV FERRING BV (NL) 2003-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030216450-A1 Inhibitors of dipeptidyl peptidase IV DPP4, DPP7, DPP8 DPP4 1/4885DPP7 2/4885DPP8 3/4885
US-20040082497-A1 Inhibitors of dipeptidyl peptidase IV DPP4, DPP7, DPP3 DPP4 1/4885DPP7 2/4885DPP8 6/4885
US-20050004205-A1 Novel dipeptidyl peptidase iv (dp-iv) inhibitors as anti-diabetic agents DPP4, DPP8, DPP3 DPP4 1/4885DPP7 4/4885DPP8 2/4885
US-20050043299-A1 Inhibitors of dipeptidyl peptidase iv DPP4, DPP9, DPP3 DPP4 1/4885DPP7 4/4885DPP8 9/4885
US-20080255126-A1 Inhibitors of post-proline cleaving proteases PREP, PEPD, DPP4 DPP4 3/4885DPP7 7/4885DPP8 16/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.